Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Amino Acids and Derivatives>Tirzepatide
Tirzepatide
  • Tirzepatide
  • Tirzepatide
  • Tirzepatide
  • Tirzepatide
  • Tirzepatide

Tirzepatide NEW

Price Get Latest Price
Package 1box
Min. Order: 10box
Supply Ability: 10000box
Update Time: 2024-04-18

Product Details

Product Name: Tirzepatide CAS No.: 2023788-19-2
Min. Order: 10box Purity: 99%
Supply Ability: 10000box Release date: 2024/04/18

Manufacturer Provide Lyophilized Peptides Tirzepatide Powder Gip/GLP-1 Tirzepatide for Weight Loss 5mg 10mg 15mg CAS 2023788-19-2


Article illustration

Introduction

Product Name: Tirzepatide

Other Name :Tirzepatide;GIP\GLP-1;Tirzepatide (LY3298176);Trizepatide;Gip\GLP-1 Tirzepatide Ly3298176 Peptide;Tilposide;Tirzepatide(GLP-1);terzapitide

CAS NO:2023788-19-2

Purity: 99%min
Appearance:White Powder

Storage:Keep in dark place,Inert atmosphere,Store in freezer, under -20°C


Tirzepatide is a once-weekly glucose-dependent insulin-stimulating polypeptide (GIP, aka: gastric inhibitory polypeptide) receptor and glucagon-like peptide-1 (GLP-1) receptor dual agonist developed by Lilly. ChemicalbookGIP and GLP-1 are both hormones secreted by the gut that promote insulin secretion. tirzepatide combines the effects of two insulin-promoting drugs into a single molecule and represents a new class of drugs for the treatment of type 2 diabetes.

Usage

Tirzepatide has a similar sequence to semaglutide, and the lys side chain in the sequence has PEG modification, which is the functional group of the polypeptide, and can increase the water solubility of the sequence. The main physiological function of TirzepChemicalbookatide is glucose-dependent insulin nutrition polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor double agonist, which is being developed for the treatment of type 2 diabetes and has entered the clinical stage.

Tirzepatide is dosed at 5-15mg per week

Semaglutide is dosed at 0.5-2.4mg per week

Application&Function

The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with
overweight and at least one weight-related condition, according to an agency press release.

This is a once-weekly injectable, which is more tolerable way of managing obesity vs. other treatments. The STEP
study data showed semaglutide 2.4 mg crosses the magic threshold of 10% weight loss for many people who received it.
This is another tool that will allow clinicians to better manage obesity.


1.Helps prevent your liver from making too much sugar
2.Helps the pancreas produce more insul when your blood sugar levels are high control blood glucose
3.Can reduce hyperglycemia, especially after meals Can reduce fasting insul and fasting glucose
4.Can reduce hemoglobin A1c,Can decrease appetite and caloric intake, while inhibiting weight gain
5.Has been shown to lower triglyceride levels and oxidative stress from high LDL
6.Has been shown to help induce weight loss in obese patients with higher dosing
Article illustration



Company Profile Introduction

Shaanxi TNJONE Pharmaceutical Co., Ltd supplies more than 2,000 kinds of products, covering the whole field of health industry, including human APIs, veterinary APIs, food additives, natural nutrition ingredients, feed additives, cosmetic additives, intermediates etc. With global sourcing advantages, the group is fully capable of meeting the one-stop sourcing needs of global customers. Today, Shaanxi TNJONE Pharmaceutical Co., Ltd.'s marketing network has spread over more than 100 countries and regions on five continents, providing professional service for global customers.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$500.00/1gram
VIP0Y
河北晟算化工有限公司
2024-08-08
$0.00/1box
VIP5Y
Jinan Jianfeng Chemical Co., Ltd
2024-08-07
$0.00/1g
VIP1Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2024-08-02
$1.00/1box
VIP1Y
Jinan Million Pharmaceutical Co., Ltd
2024-07-30
$65.00/1Box
VIP1Y
Qingdao Xinli Technology Development Co., Ltd.
2024-07-25
$165.00/1box
VIP1Y
Binzhou Lista Trading Limited
2024-07-02
$20.00/10mg
VIP2Y
Zhuzhou New Peptides Tech Co.,Ltd.
2024-06-20
$5.00/5mg
VIP1Y
Hebei Ganmiao New material Technology Co., LTD
2024-06-06
$0.10/20mg
VIP1Y
Shanghai Likang New Materials Co., Limited
2024-05-27
$80.00/1box
VIP1Y
Strong peptide cross-border e-commerce Co. LTD
2024-05-23

Shaanxi TNJONE Pharmaceutical Co., Ltd

1YR ChinaChina
  • Since: 2019-05-23
  • Address: No. 4C-11-A392, Financial Port, Northwest corner of Fengjing Avenue and Fengxin Road, Fengdong New C
INQUIRY